These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 24148205)

  • 1. Cross-talk of membrane lipids and Alzheimer-related proteins.
    Walter J; van Echten-Deckert G
    Mol Neurodegener; 2013 Oct; 8():34. PubMed ID: 24148205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. γ-Secretase, apolipoprotein E and cellular cholesterol metabolism.
    Walter J
    Curr Alzheimer Res; 2012 Feb; 9(2):189-99. PubMed ID: 21605030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?
    Dunys J; Valverde A; Checler F
    J Biol Chem; 2018 Oct; 293(40):15419-15428. PubMed ID: 30143530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.
    Steiner H; Capell A; Leimer U; Haass C
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(6):266-70. PubMed ID: 10653281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A partial failure of membrane protein turnover may cause Alzheimer's disease: a new hypothesis.
    Sambamurti K; Suram A; Venugopal C; Prakasam A; Zhou Y; Lahiri DK; Greig NH
    Curr Alzheimer Res; 2006 Feb; 3(1):81-90. PubMed ID: 16472208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingolipids: critical players in Alzheimer's disease.
    van Echten-Deckert G; Walter J
    Prog Lipid Res; 2012 Oct; 51(4):378-93. PubMed ID: 22835784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant proteolytic processing and therapeutic strategies in Alzheimer disease.
    Tomita T
    Adv Biol Regul; 2017 May; 64():33-38. PubMed ID: 28082052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of β-Amyloid Precursor Protein in Alzheimer's Disease.
    Tcw J; Goate AM
    Cold Spring Harb Perspect Med; 2017 Jun; 7(6):. PubMed ID: 28003277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism.
    Gandy S; Petanceska S
    Biochim Biophys Acta; 2000 Jul; 1502(1):44-52. PubMed ID: 10899430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].
    Xu BG; Wu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BACE1: the beta-secretase enzyme in Alzheimer's disease.
    Vassar R
    J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APP processing in Alzheimer's disease.
    Zhang YW; Thompson R; Zhang H; Xu H
    Mol Brain; 2011 Jan; 4():3. PubMed ID: 21214928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc and Copper Differentially Modulate Amyloid Precursor Protein Processing by γ-Secretase and Amyloid-β Peptide Production.
    Gerber H; Wu F; Dimitrov M; Garcia Osuna GM; Fraering PC
    J Biol Chem; 2017 Mar; 292(9):3751-3767. PubMed ID: 28096459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APP metabolism regulates tau proteostasis in human cerebral cortex neurons.
    Moore S; Evans LD; Andersson T; Portelius E; Smith J; Dias TB; Saurat N; McGlade A; Kirwan P; Blennow K; Hardy J; Zetterberg H; Livesey FJ
    Cell Rep; 2015 May; 11(5):689-96. PubMed ID: 25921538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. γ-Secretase and its modulators: Twenty years and beyond.
    Xia W
    Neurosci Lett; 2019 May; 701():162-169. PubMed ID: 30763650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging beta-amyloid therapies for the treatment of Alzheimer's disease.
    Conway KA; Baxter EW; Felsenstein KM; Reitz AB
    Curr Pharm Des; 2003; 9(6):427-47. PubMed ID: 12570807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-β and Tau at the Crossroads of Alzheimer's Disease.
    Gallardo G; Holtzman DM
    Adv Exp Med Biol; 2019; 1184():187-203. PubMed ID: 32096039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.